|
1
|
Ambros V: The functions of animal
microRNAs. Nature. 431:350–355. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Xu Z, Han Y, Liu J, Jiang F, Hu H, Wang Y,
Liu Q, Gong Y and Li X: MiR-135b-5p and MiR-499a-3p promote cell
proliferation and migration in atherosclerosis by directly
targeting MEF2C. Sci Rep. 5:122762015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ndrepepa G, Colleran R and Kastrati A:
Gamma-glutamyl transferase and the risk of atherosclerosis and
coronary heart disease. Clin Chim Acta. 476:130–138. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Zhang H, Jia K, Sun D and Yang M:
Protective effect of HSP27 in atherosclerosis and coronary heart
disease by inhibiting reactive oxygen species. J Cell Biochem. Dec
12–2017.(Epub ahead of print). View Article : Google Scholar
|
|
5
|
Zhu N, Zhang D, Chen S, Liu X, Lin L,
Huang X, Guo Z, Liu J, Wang Y, Yuan W and Qin Y: Endothelial
enriched microRNAs regulate angiotensin II-induced endothelial
inflammation and migration. Atherosclerosis. 215:286–293. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Quan X, Ji Y, Zhang C, Guo X, Zhang Y, Jia
S, Ma W, Fan Y and Wang C: Circulating MiR-146a may be a potential
biomarker of coronary heart disease in patients with subclinical
hypothyroidism. Cell Physiol Biochem. 45:226–236. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Jiang Y, Wang HY, Li Y, Guo SH, Zhang L
and Cai JH: Peripheral blood miRNAs as a biomarker for chronic
cardiovascular diseases. Sci Rep. 4:50262014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Hoekstra M, van der Lans CA, Halvorsen B,
Gullestad L, Kuiper J, Aukrust P, van Berkel TJ and Biessen EA: The
peripheral blood mononuclear cell microRNA signature of coronary
artery disease. Biochem Biophys Res Commun. 394:792–797. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Liu H, Yang N, Fei Z, Qiu J, Ma D, Liu X,
Cai G and Li S: Analysis of plasma miR-208a and miR-370 expression
levels for early diagnosis of coronary artery disease. Biomed Rep.
5:332–336. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Märkl B, Wilhelms N, Anthuber M,
Schenkirsch G, Schlimok G and Oruzio D: Circulating
cytokeratin-positive cells and tumor budding in colorectal cancer.
World J Clin Oncol. 7:433–440. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zeng L, Chen Y, Wang Y, Yu LR, Knox B,
Chen J, Shi T, Chen S, Ren Z, Guo L, et al: MicroRNA hsa-miR-370-3p
suppresses the expression and induction of CYP2D6 by facilitating
mRNA degradation. Biochem Pharmacol. 140:139–149. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wu Z, Sun H, Zeng W, He J and Mao X:
Upregulation of MircoRNA-370 induces proliferation in human
prostate cancer cells by downregulating the transcription factor
FOXO1. PLoS One. 7:e458252012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Xing YQ, Li A, Yang Y, Li XX, Zhang LN and
Guo HC: The regulation of FOXO1 and its role in disease
progression. Life Sci. 193:124–131. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Pan CW, Jin X, Zhao Y, Pan Y, Yang J,
Karnes RJ, Zhang J, Wang L and Huang H: AKT-phosphorylated FOXO1
suppresses ERK activation and chemoresistance by disrupting
IQGAP1-MAPK interaction. EMBO J. 36:995–1010. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Iliopoulos D, Drosatos K, Hiyama Y,
Goldberg IJ and Zannis VI: MicroRNA-370 controls the expression of
microRNA-122 and Cpt1alpha and affects lipid metabolism. J Lipid
Res. 51:1513–1523. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Kai F, Laklai H and Weaver VM: Force
Matters: Biomechanical regulation of cell invasion and migration in
disease. Trends Cell Biol. 26:486–497. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Mi J, Zhang X, Giangrande PH, McNamara JO
II, Nimjee SM, Sarraf-Yazdi S, Sullenger BA and Clary BM: Targeted
inhibition of alphavbeta3 integrin with an RNA aptamer impairs
endothelial cell growth and survival. Biochem Biophys Res Commun.
338:956–963. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Berry E, Hardt JL, Clardy J, Lurain JR and
Kim JJ: Induction of apoptosis in endometrial cancer cells by
psammaplysene A involves FOXO1. Gynecol Oncol. 112:331–336. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Tsuchiya K and Ogawa Y: Forkhead box class
O family member proteins: The biology and pathophysiological roles
in diabetes. J Diabetes Investig. 8:726–734. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Deng L, Huang L, Sun Y, Heath JM, Wu H and
Chen Y: Inhibition of FOXO1/3 promotes vascular calcification.
Arterioscler Thromb Vasc Biol. 35:175–183. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Li Y, Ren M, Wang X, Cui X, Zhao H, Zhao
C, Zhou J, Guo Y, Hu Y, Yan C, et al: Glutaredoxin 1 mediates the
protective effect of steady laminar flow on endothelial cells
against oxidative stress-induced apoptosis via inhibiting Bim. Sci
Rep. 7:155392017. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zhu C, Zhu Q, Wu Z, Yin Y, Kang D, Lu S
and Liu P: Isorhapontigenin induced cell growth inhibition and
apoptosis by targeting EGFR-related pathways in prostate cancer. J
Cell Physiol. 233:1104–1119. 2018. View Article : Google Scholar : PubMed/NCBI
|
